Latest Breaking News On - ஜோசப் ஸ்க்வார்ட்ஸ் - Page 6 : comparemela.com

Crinetics Pharmaceuticals Stock Is Showing Strong Insider Interest Kailas Salunkhe- April 21, 2021, 10:32 AM EDT SHARE ON: CRNX) has seen a key corporate insider snap up shares recently. Regulations require corporate insiders to make their trading activity public, and their actions could signal to investors that now is the time to get in on the action. In the last 12 days, corporate insider Perceptive Advisors LLC, which owns a more than 10% stake in the company, has bought $5 million worth of Crinetics shares. (See Crinetics stock analysis on TipRanks) On March 31, H. C. Wainwright analyst Douglas Tsao reiterated a Buy rating on the stock with a $30 price target (81.3% upside potential).

Douglas tsaoJoseph schwartzPerceptive advisorsCrinetics pharmaceuticals incCrinetics pharmaceuticalsLeerink partnersModerate buyடக்ளஸ் ட்‌ஸ்ம்ஜோசப் ஸ்க்வார்ட்ஸ்கிரினெடிக்ஸ் மருந்துகள் இன்க்கிரினெடிக்ஸ் மருந்துகள்மிதமான வாங்க